Last checked at 27 Feb 2024 07:00
27 February 2024
Dr. Martens plc
CFO appointment update
Dr. Martens plc ('the Company') announces that Giles Wilson, who has been appointed to the role of Chief Financial Officer (CFO), will join the business and Board on 27th May 2024 and will present the FY24 results on 30th May 2024.
The Company also confirms that Giles and Katie Wilson, a person closely associated with him, have purchased a total of 57,400 shares in Dr. Martens plc on the open market since his appointment was first announced.
Enquiries
Investors and analysts
Bethany Barnes, Director of Investor Relations Bethany.Barnes@drmartens.com +44 7825 187465
Beth Callum, Senior Investor Relations Analyst Beth.Callum@drmartens.com +44 203 995 2644
Press
H/Advisors Maitland +44 207 379 5151
Katharine Spence +44 7384 535739
Gill Hammond, Director of Communications +44 7384 214248
About Dr. Martens
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Produced originally for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DM's" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company is a constituent of the FTSE 250 index.